Fierce Biotech July 22, 2022
Conor Hale

ForSight Robotics aims to bring the benefits of a steady, remote-controlled hand to cataract eye surgery, and, now, the Israeli startup is $55 million closer to its goal.

The company previously raised $10 million in a seed funding round last year to advance its Oryom microsurgery system to help automate the complex tasks of removing a clouded lens from the eye and replacing it with a clearer artificial one.

The new funding will be used to help move Oryom into clinical trials as well as to help develop the system for other eye-related procedures such as retinal diseases and glaucoma, the company said.

The startup’s ultimate goal is to make the sophisticated ophthalmic procedure more accessible internationally...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Robotics/RPA, Technology, Trends
Microsoft releases a new genAI model that can control robots
No, Apple and Meta aren’t making humanoid robots
Retina surgery robot shows early promise
The next 5 years: Game-changing tech for ASCs
Meta Is Developing Humanoid Robots. This Has Huge Potential For Healthcare

Share This Article